The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug
SAN DIEGO — Neurocrine Biosciences, a biotech focused on treating rare neurological and endocrine diseases, announced on Thursday that its experimental drug for congenital adrenal
October 5, 2023